TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 8 | 0 | 0 | -5 | 4 | 4 | 15 | 5 |
| S | %wins | 63 | 63 | 63 | 63 | 38 | 38 | 54 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/9/19 21:10 | 12/5/19 | GNMX | Aevi Genomic Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Barer Sol J | PA | D | S | -549 | 0.1340 | 0 | -4,099 | -100 | 0 | M | |||||||||||||||
1/14/11 16:35 | 1/13/11 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Barer Sol J | NJ | D | S.d | -4,315 | 57.38 | 33 | -75 | -9 | 753 | D | 18 | -2 | 10 | -1 | -5 | -4 | -2 | 1 | -1 | -2 | -7 | -2 | 6 | 27 | |
9/16/09 16:06 | 9/14/09 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Barer Sol J | NJ | DO | CEO | S.d | -31,274 | 52.12 | 33 | -600 | -50 | 605 | D | -24 | -25 | 8 | 21 | -9 | -2 | 3 | 2 | -1 | 2 | 3 | 0 | 21 | 2 |
10/31/08 16:37 | 10/30/08 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Barer Sol J | NJ | DO | CEO | S | -15,869 | 63.38 | 33 | -250 | -29 | 605 | D | 28 | -3 | -1 | -13 | -6 | 17 | 17 | 16 | 2 | -5 | -26 | -17 | -39 | -21 |
8/1/08 16:35 | 7/30/08 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Barer Sol J | NJ | DO | CEO | S | -5,898 | 73.73 | 33 | -80 | -9 | 778 | D | 58 | 26 | 35 | 19 | 24 | 5 | 4 | 3 | -1 | 0 | -6 | -16 | -28 | -22 |
5/13/08 16:03 | 5/12/08 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Barer Sol J | NJ | DO | CEO | S.d | -55,785 | 61.77 | 33 | -903 | -51 | 858 | D | 44 | -4 | -4 | 6 | -3 | -2 | -3 | -2 | 1 | -1 | -1 | 25 | 0 | -30 |
6/8/07 17:48 | 6/7/07 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Barer Sol J | NJ | DO | CEO | S.m | -27,417 | 59.12 | 33 | -464 | -37 | 791 | D | 186 | 37 | -1 | 11 | -8 | -11 | -7 | -7 | 2 | 2 | 1 | 14 | 3 | 5 |
12/30/05 15:26 | 12/28/05 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Barer Sol J | NJ | DO | COO,P | S.d | -33,551 | 60.48 | 33 | -555 | -60 | 376 | M | 188 | 142 | 59 | 21 | 7 | 7 | 14 | 11 | 0 | 6 | 10 | 36 | 46 | 77 |
11/3/04 19:25 | 11/2/04 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Barer Sol J | NJ | DO | COO | S | -5,055 | 29.92 | 33 | -169 | -35 | 313 | D | 170 | 44 | 15 | 14 | 2 | -3 | 7 | 1 | -2 | -2 | -10 | -12 | 24 | 84 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |